{
  "url": "https://finance.yahoo.com/news/introducing-auryis-ai-powered-unified-033000697.html",
  "authorsByline": "PR Newswire",
  "articleId": "42cc43cc99ae4e47a2f409af96813375",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/prnewswire.com/c0b29ebfd814596d04b83326f48e7a37",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-25T03:30:00+00:00",
  "addDate": "2025-08-25T03:40:28.222831+00:00",
  "refreshDate": "2025-08-25T03:40:28.222833+00:00",
  "score": 1.0,
  "title": "Introducing Auryis AI-Powered Unified Compliance for Pharma & Life Sciences",
  "description": "Canarys (ISIN: INE0QG301017) is proud to announce the launch of Auryis, their AI-powered, unified compliance assessment platform purpose-built for Pharma and Life Sciences. This marks a pivotal step in Canarys' evolution\u2014from a services-led organization to a product-led company.",
  "content": "BENGALURU, India, Aug. 25, 2025 /PRNewswire/ -- Canarys (ISIN: INE0QG301017) is proud to announce the launch of Auryis, their AI-powered, unified compliance assessment platform purpose-built for Pharma and Life Sciences. This marks a pivotal step in Canarys' evolution\u2014from a services-led organization to a product-led company.\n\nIn a fast-changing regulatory landscape, Auryis delivers real-time, structured, and audit-ready compliance insights across all digital content\u2014including SOPs, clinical trial documents, training materials, and marketing assets. It intelligently maps each element to external regulations (GxP, FDA, EMA), internal standards, and custom business rules\u2014helping organizations anticipate and mitigate non-compliance risk before it escalates.\n\u2022 Custom rule integration: Adapts quickly to new policies, study conditions, and temporary guidance.\n\u2022 Continuous learning: Keeps pace with evolving global regulations, reducing manual workload and review cycles.\n\nCEO, Canarys, Sheshadri Srinivas commented: \"In today's complex regulatory environment, Pharma and Life Sciences organizations face mounting pressure\u2014manual reviews, rapidly shifting global standards, and the costly consequences of compliance gaps that can delay approvals and impact patient safety.\n\nAuryis addresses these challenges head-on, transforming compliance into a faster, smarter, and continuous process. Powered by AI and reinforced by expert validation, it delivers audit-ready insights, lowers non-compliance risk, and drives operational excellence.\n\nThis launch is a defining milestone in Canarys' journey. With Auryis, we are stepping confidently into a product-led future\u2014creating durable value for our clients, investors, and partners.\"\n\nAuryis: Compliance accelerated by AI, elevated by human expertise. Gain confidence, consistency, and operational excellence.\n\nCanarys Automations Limited (formerly known as Canarys Automations Private Limited) headquartered in Bengaluru, India, boasts over 30 years of experience as a leading IT solutions provider. With a team of over 350 technology professionals, the company specializes in facilitating digital transformation for businesses through its software solutions in Digitalization, Modernization, Cloudification, Automation, and Intelligence. Their solutions cater to various industry sectors, including BFSI, Retail, Healthcare, Pharmaceutical, Manufacturing and Water Resources Management with a primary focus on enhancing operations, improving customer experience, and staying competitive.",
  "medium": "Article",
  "links": [
    "https://mma.prnewswire.com/media/2756165/Auryis_Launch.html"
  ],
  "labels": [
    {
      "name": "Press Release"
    }
  ],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "compliance gaps",
      "weight": 0.082740925
    },
    {
      "name": "non-compliance risk",
      "weight": 0.082465835
    },
    {
      "name": "Compliance",
      "weight": 0.08109074
    },
    {
      "name": "compliance",
      "weight": 0.08109074
    },
    {
      "name": "Canarys Automations Private Limited",
      "weight": 0.0710528
    },
    {
      "name": "Auryis",
      "weight": 0.07067797
    },
    {
      "name": "Canarys Automations Limited",
      "weight": 0.07039279
    },
    {
      "name": "evolving global regulations",
      "weight": 0.06415766
    },
    {
      "name": "Canarys",
      "weight": 0.063537665
    },
    {
      "name": "custom business rules",
      "weight": 0.06242598
    }
  ],
  "topics": [
    {
      "name": "AI"
    }
  ],
  "categories": [
    {
      "name": "Tech"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Company News",
      "score": 0.9658203125
    },
    {
      "name": "/Computers & Electronics/Software/Business & Productivity Software",
      "score": 0.8359375
    },
    {
      "name": "/Business & Industrial/Business Operations/Management",
      "score": 0.60595703125
    },
    {
      "name": "/Business & Industrial/Pharmaceuticals & Biotech",
      "score": 0.568359375
    },
    {
      "name": "/Computers & Electronics/Enterprise Technology/Other",
      "score": 0.529296875
    },
    {
      "name": "/Computers & Electronics/Enterprise Technology/Data Management",
      "score": 0.362060546875
    },
    {
      "name": "/Science/Computer Science/Machine Learning & Artificial Intelligence",
      "score": 0.353759765625
    },
    {
      "name": "/Health/Medical Facilities & Services/Other",
      "score": 0.3056640625
    }
  ],
  "sentiment": {
    "positive": 0.79878676,
    "negative": 0.02486267,
    "neutral": 0.17635058
  },
  "summary": "Canarys (ISIN: INE0QG301017) has launched Auryis, their AI-powered, unified compliance assessment platform for Pharma and Life Sciences. This is part of Canary's evolution from a services-led organization to a product-led company. Aryis delivers real-time, structured, and audit-ready compliance insights across all digital content, including SOPs, clinical trial documents, training materials, and marketing assets. It maps each element to external regulations (GxP, FDA, EMA), internal standards, and custom business rules. The platform also adapts quickly to new policies, study conditions, and temporary guidance.",
  "shortSummary": "Canarys Automations launched Auryis, an AI-powered compliance platform for Pharma and Life Sciences, aiming to enhance compliance, consistency, and operational excellence within these sectors.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": false,
  "reprintGroupId": "3241f2f89f894fb5a6ed840f4edf85bb",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://media.zenfs.com/en/prnewswire.com/c0b29ebfd814596d04b83326f48e7a37",
      "text": "\ufffd\ufffd\ufffd\ufffd JFIF ` ` \ufffd\ufffd\ufffdPhotoshop 3.0 8BIM pZ %Gx qCelebrating the launch of Auryis, Canarys\u2019 AI-powered unified compliance platform for Pharma and Life Sciences.Z BENGALURUt e P Hand-out_ i Auryis Launch Auryis Launch7 2025:08:24s Canarys Automations Ltdn Canarys Automations Ltdg z CN( See Release *WebsiteDistribution|EntermediaDistribution \ufffd\ufffdICC_PROFILE lcms mntrRGB XYZ \ufffd ) 9acspAPPL \ufffd\ufffd \ufffd-lcms desc \ufffd ^cprt \\ wtpt h bkpt | rXYZ \ufffd gXYZ \ufffd bXYZ \ufffd rTRC \ufffd @gTRC \ufffd @bTRC \ufffd @desc c2 text FB XYZ \ufffd\ufffd \ufffd-XYZ 3 \ufffdXYZ o\ufffd 8\ufffd \ufffdXYZ b\ufffd \ufffd\ufffd \ufffdXYZ $\ufffd \ufffd \ufffd\ufffdcurv \ufffd\ufffdc\ufffdk\ufffd?Q4!\ufffd)\ufffd2;\ufffdFQw]\ufffdkpz\ufffd\ufffd\ufffd|\ufffdi\ufffd}\ufffd\ufffd\ufffd0\ufffd\ufffd\ufffd\ufffd C \ufffd\ufffd C \ufffd\ufffd \ufffd\" \ufffd\ufffd \ufffd\ufffd R !1A\"Qa2q\ufffdB\ufffd\ufffd#\ufffd 3Rb\ufffd\ufffd$r\ufffd\ufffd%CS\ufffd\ufffd\ufffd4cd\ufffd\ufffd\ufffd\ufffd\ufffd'E\ufffd\ufffd\u04f3\ufffd\ufffd\ufffd\ufffd \ufffd\ufffd : !1AQaq\ufffd\ufffd\"\ufffd\ufffd\ufffd\ufffd2B\ufffd\ufffd#Rb3\ufffd$Sr\ufffd\ufffd ? \ufffd\ufffd_``c\ufffdB\ufffd!\ufffd\ufffd\ufffd\ufffd\ufffd8(,c [\ufffd\ufffd!\ufffd\ufffd\\\ufffd\ufffd\ufffd\ufffd\ufffdw7\ufffd\ufffd'\ufffd+\ufffd\ufffd_\ufffd\ufffd\ufffd^\ufffdEz\ufffd\ufffdKl\ufffd\ufffd\ufffd\ufffd\"Q\ufffd\ufffd\ufffd\ufffd\ufffdkY\ufffd\ufffdd\ufffd2h\ufffd-W $ z\u0613\ufffd\ufffd\ufffdH244\ufffd\ufffd\ufffdBM\ufffd\ufffd\u031f\ufffd\ufffd\ufffd,\ufffd\\\u0257\ufffdm\ufffd\ufffd\ufffdr\ufffdiJE\ufffd \ufffd\ufffd\ufffd\ufffdlC\ufffdS\ufffd\ufffdi\ufffd4J\ufffd\ufffdU\ufffdTq\u05d31i1\ufffdU\ufffd\ufffd'c\ufffd\ufffd\ufffda%B\ufffd\ufffd\ufffd\ufffdX\ufffd\ufffd\ufffd\ufffd\ufffdid\ufffd\ufffd|f8\ufffd\ufffd\ufffd\ufffds\ufffd|\ufffd\ufffds}\ufffd\ufffd.\ufffd\ufffd\u0722\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffdhI\ufffdn\ufffd\ufffd\ufffd\ufffdrrV \ufffdFQ$\ufffd\ufffdh\ufffd _\ufffd\ufffd\"\ufffd\ufffd3ium\ufffd\ufffdt\ufffd\ufffdi\ufffd\ufffd\ufffdu\ufffd\ufffd\ufffdgP]\ufffd\ufffdw\ufffd\ufffd\ufffdD N\ufffd\ufffd\ufffd \ufffd\ufffde\ufffd(\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffdA9w\ufffd\ufffd\ufffd\ufffd!\ufffdZ\ufffd)\ufffd[\ufffd@\ufffd\ufffd\ufffd\ufffd\ufffd?\ufffd-0 \ufffd\ufffd\ufffd=1\ufffd6\ufffd\ufffd|$%\ufffdI\ufffdP\ufffd\ufffd\ufffd\ufffd1\ufffd\ufffdX\u052e\ufffd \ufffdDX\ufffd\ufffd\ufffd\ufffd0C8\ufffdE\ufffd-p./k\ufffd\ufffd_|`.N\ufffds\ufffd\u01e4\ufffd \ufffd\u04d6\ufffd\ufffd!o*V\ufffdT\ufffd\ufffdL\ufffdK\\\ufffd\ufffd\ufffdA\ufffdS\ufffd\ufffd\u015c#Ryc\ufffd\ufffdo\ufffd\ufffd\ufffd][i\ufffdK\ufffd\ufffdR \ufffd\ufffd{l\ufffd\ufffd#jP\ufffd\ufffd\ufffd NeLJ\ufffd\ufffd\u0610\u0485\ufffdn!E*I\ufffd(\ufffd\ufffdr-\ufffd\\&\ufffd6X\u01a4cl`\ufffdr+\ufffd(\ufffd\ufffd\ufffd\ufffdK\ufffd\ufffd4\ufffd\ufffd~x\ufffd;\ufffd\ufffd \\\ufffd\ufffd\ufffdT,m\ufffd`J\ufffd\ufffdo\ufffd\ufffd|ag|[\ufffd\ufffd(\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\u040c\ufffd\u07f69\ufffddBB+\\d\ufffd\ufffd\ufffd00 \ufffd-\ufffd$ \ufffd6\ufffd\ufffd\ufffd8PIX\ufffd\ufffd _`\ufffd\ufffd [\ufffd\ufffd\ufffdAU\ufffd@:\ufffd\ufffdP\\\ufffd&\u00eflve\ufffd\ufffd\ufffd\u5377#\ufffd\ufffd\ufffd\ufffd0\ufffdK[_\ufffd>\ufffd\ufffdV\ufffdm\ufffdG\ufffd}q\ufffd!u\ufffdN{Q\ufffdi\ufffd}\ufffd\ufffdc\ufffdfd\ufffd.kR\ufffd\ufffdV\ufffd\ufffd\ufffdP\ufffd\ufffd\u01a2O^\ufffd?L\u00ef'Ao1\u0417@em\ufffd\ufffd\ufffd?\ufffd&%@\ufffd \ufffd8 R\ufffd\ufffd\ufffd\ufffd:\ufffdE\ufffdI/\ufffdm\ufffd\ufffd&\ufffdj\ufffd\"E\ufffd9?\ufffdod\ufffd\u032f\ufffd\u0539\ufffd \ufffd\ufffd!\ufffd\ufffd\ufffd)\ufffd+/R+\ufffd}O\ufffd\\\u02e6\ufffdJCw\ufffd\ufffd\u06a8\u06d2i\ufffdG\ufffd\ufffd\ufffde\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffdU\ufffdS\ufffd58u#fB\ufffdX\ufffd\ufffd\u0494T\ufffd@\ufffd(?\ufffd\ufffd\u0139\ufffdse\ufffd\ufffd\ufffd\ufffd\ufffd\ufffdfR\ufffd\ufffd\ufffdL\u0360)\ufffd\ufffdP\ufffd.\ufffdsN8\ufffdV\ufffd\ufffdk \ufffd`\ufffd\ufffdqYS\ufffd\ufffd\ufffd~\ufffd\ufffd\ufffd'\ufffdW-`p\ufffd9xn}>\ufffd\ufffd\ufffd/\ufffd\ufffdzw\ufffd5:J\ufffd4j\ufffdki\ufffd \ufffd\ufffd\ufffd\ufffd\u0629\ufffd\ufffd[\ufffd\ufffdbn\ufffd\ufffd \ufffd\ufffd4e^\ufffdw\ufffde\ufffd\ufffdG\ufffd\ufffdZ`\ufffd^\\t\ufffd\ufffd .(%\ufffdn\ufffdwR\ufffdS\ufffd\u0757sd\ufffd7!gj"
    }
  ],
  "argos_summary": "Canarys Automations Ltd announced the launch of Auryis, an AI\u2011powered compliance platform tailored for the pharmaceutical and life\u2011sciences sectors. The tool delivers real\u2011time, audit\u2011ready insights across digital content\u2014SOPs, clinical documents, training materials, and marketing assets\u2014by mapping them to regulations such as GxP, FDA, and EMA, and to custom business rules. Auryis incorporates continuous learning and custom rule integration to adapt quickly to evolving regulations, reducing manual review cycles and mitigating non\u2011compliance risk. The launch marks Canarys\u2019 transition from a services\u2011led to a product\u2011led company, aiming to provide durable value to clients, investors, and partners.",
  "argos_id": "IUEWE5ESR"
}